Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Ferrari

Showing results (121-130 of 151) with videos related to

Pageof 16
Sort By:
Cancer Medicine|February 9, 2020
Individual and joint effects of metformin and statins on mortality among patients with high-risk prostate cancerXiang-Lin Tan, Jian-Yu E, Yong Lin, et al.
Cancers|November 14, 2019
Synergism Through WEE1 and CHK1 Inhibition in Acute Lymphoblastic LeukemiaAndrea Ghelli Luserna Di Rorà, Matteo Bocconcelli, Anna Ferrari, et al.
Frontiers in Oncology|June 21, 2021
Adrenomedullin Expression Characterizes Leukemia Stem Cells and Associates With an Inflammatory Signature in Acute Myeloid LeukemiaGiorgia Simonetti, Davide Angeli, Elisabetta Petracci, et al.
Haematologica|June 11, 2010
The PAX5 gene is frequently rearranged in BCR-ABL1-positive acute lymphoblastic leukemia but is not associated with outcome. A report on behalf of the GIMEMA Acute Leukemia Working PartyIlaria Iacobucci, Annalisa Lonetti, Francesca Paoloni, et al.
Biomedicines|April 30, 2021
Pharmacological Inhibition of WIP1 Sensitizes Acute Myeloid Leukemia Cells to the MDM2 Inhibitor Nutlin-3aMaria Chiara Fontana, Jacopo Nanni, Andrea Ghelli Luserna di Rorà, et al.
Leukemia|June 29, 2023
MEK1/2 regulate normal BCR and ABL1 tumor-suppressor functions to dictate ATO response in TKI-resistant Ph+ leukemiaLaura Mazzera, Manuela Abeltino, Guerino Lombardi, et al.
Leukemia|June 24, 2026
Retraction Note: MEK1/2 regulate normal BCR and ABL1 tumor-suppressor functions to dictate ATO response in TKI-resistant Ph+ leukemiaLaura Mazzera, Manuela Abeltino, Guerino Lombardi, et al.
Oncotarget|February 18, 2016
Targeting the p53-MDM2 interaction by the small-molecule MDM2 antagonist Nutlin-3a: a new challenged target therapy in adult Philadelphia positive acute lymphoblastic leukemia patientsStefania Trino, Ilaria Iacobucci, Daniela Erriquez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2011
CDKN2A/B alterations impair prognosis in adult BCR-ABL1-positive acute lymphoblastic leukemia patientsIlaria Iacobucci, Anna Ferrari, Annalisa Lonetti, et al.
Plos One|August 1, 2012
IKAROS deletions dictate a unique gene expression signature in patients with adult B-cell acute lymphoblastic leukemiaIlaria Iacobucci, Nunzio Iraci, Monica Messina, et al.
Pageof 16

Showing results (121-130 of 151) with videos related to

Sort By:
Pageof 16
Cancer Medicine|February 9, 2020
Individual and joint effects of metformin and statins on mortality among patients with high-risk prostate cancerXiang-Lin Tan, Jian-Yu E, Yong Lin, et al.
Cancers|November 14, 2019
Synergism Through WEE1 and CHK1 Inhibition in Acute Lymphoblastic LeukemiaAndrea Ghelli Luserna Di Rorà, Matteo Bocconcelli, Anna Ferrari, et al.
Frontiers in Oncology|June 21, 2021
Adrenomedullin Expression Characterizes Leukemia Stem Cells and Associates With an Inflammatory Signature in Acute Myeloid LeukemiaGiorgia Simonetti, Davide Angeli, Elisabetta Petracci, et al.
Haematologica|June 11, 2010
The PAX5 gene is frequently rearranged in BCR-ABL1-positive acute lymphoblastic leukemia but is not associated with outcome. A report on behalf of the GIMEMA Acute Leukemia Working PartyIlaria Iacobucci, Annalisa Lonetti, Francesca Paoloni, et al.
Biomedicines|April 30, 2021
Pharmacological Inhibition of WIP1 Sensitizes Acute Myeloid Leukemia Cells to the MDM2 Inhibitor Nutlin-3aMaria Chiara Fontana, Jacopo Nanni, Andrea Ghelli Luserna di Rorà, et al.
Leukemia|June 29, 2023
MEK1/2 regulate normal BCR and ABL1 tumor-suppressor functions to dictate ATO response in TKI-resistant Ph+ leukemiaLaura Mazzera, Manuela Abeltino, Guerino Lombardi, et al.
Leukemia|June 24, 2026
Retraction Note: MEK1/2 regulate normal BCR and ABL1 tumor-suppressor functions to dictate ATO response in TKI-resistant Ph+ leukemiaLaura Mazzera, Manuela Abeltino, Guerino Lombardi, et al.
Oncotarget|February 18, 2016
Targeting the p53-MDM2 interaction by the small-molecule MDM2 antagonist Nutlin-3a: a new challenged target therapy in adult Philadelphia positive acute lymphoblastic leukemia patientsStefania Trino, Ilaria Iacobucci, Daniela Erriquez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2011
CDKN2A/B alterations impair prognosis in adult BCR-ABL1-positive acute lymphoblastic leukemia patientsIlaria Iacobucci, Anna Ferrari, Annalisa Lonetti, et al.
Plos One|August 1, 2012
IKAROS deletions dictate a unique gene expression signature in patients with adult B-cell acute lymphoblastic leukemiaIlaria Iacobucci, Nunzio Iraci, Monica Messina, et al.
Pageof 16